We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lack of Cell Adhesion Protein Paves Way for Breast Cancer Development

By LabMedica International staff writers
Posted on 09 May 2012
A protein that is deficient in some types of breast tumors has been linked to the formation of desmosomes, complex protein structures that bind cells together into tissues and organs.

Desmosomes are molecular complexes of cell adhesion and linking proteins that attach cell surface adhesion proteins to intracellular keratin cytoskeletal filaments. More...
The cell adhesion proteins of the desmosome, desmoglein and desmocollin, are members of the cadherin family of cell adhesion molecules. They are transmembrane proteins that bridge the space between adjacent epithelial cells by way of homophilic binding of their extracellular domains to other desmosomal cadherins on the adjacent cell. Both have five extracellular domains, and have calcium-binding motifs.

A protein called Perp (TP53 apoptosis effector) had been shown previously to have a role in stratified epithelial integrity and cell-cell adhesion by promoting desmosome assembly. In the current study, investigators at Stanford University (Palo Alto, CA, USA) sought to explain why mice genetically engineered to lack the gene for Perp production suffered from severe blistering of the epidermis and oral mucosa and how this type of inflammatory response was linked to formation of breast tumors.

They reported in the April 20, 2012, online edition of the journal Breast Cancer Research that Perp protein was expressed in the mammary epithelium, where it co-localized with desmosomes. Perp loss affected mammary epithelial homeostasis by causing the accumulation of inflammatory cells around mature mammary epithelium. Reduced Perp expression was detected in many human breast cancer cell lines compared to untransformed cells, and Perp-deficiency promoted the development of mouse mammary cancer.

Senior author Dr. Laura Attardi, associate professor of radiation oncology at Stanford University, said, “Perp deficiency caused defects in desmosomal protein expression in breast epithelial cells. At the same time, there was an enhanced inflammatory response in the breast tissue, and tumors tended to develop more quickly. We also found in the lab that breast cancer cells had abnormally low levels of Perp.”

Related Links:
Stanford University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.